At Holdings Channel, we have reviewed the latest batch of the 21 most recent 13F filings for the 12/31/2025 reporting period, and noticed that Palantir Technologies Inc (Symbol: PLTR) was held by 9 of these funds. When hedge fund managers appear to be thinking alike, we find it

Alphabet Inc. (NASDAQ:GOOG) is among the 8 Most Promising Metaverse Stocks to Buy According to Hedge Funds. Alphabet Inc. (NASDAQ:GOOG) is one of the most promising stocks. On February 5, UBS increased its price target on Alphabet Inc. (NASDAQ:GOOG) to $348 from $345 while maintaining a Neutral rating on the stock. The firm pointed out […]

Alphabet Inc.’s (GOOG) Generative AI Capex to Drive Up to $23B in Cloud Revenue, Says UBS Yahoo Finance

400tmax/iStock Unreleased via Getty Images Google ( GOOG )( GOOGL ) is searching for a wider market for its artificial intelligence chips, or TPUs, but that may be challenging in a market dominated by Nvidia ( NVDA ), according to The Wall Street Journal . Another challenge is marketing their TPUs to rival cloud providers, such as Amazon Web Services ( AMZN ) and Microsoft ( MSFT ) Azure, the report said. Manufacturing bottlenecks could also become an issue, as Google utilizes Taiwan Semiconductor Manufacturing Company ( TSM ) to produce its TPUs. TSM's largest client is Nvidia. What's more, another large-scale potential client, Meta Platforms ( META ), inked a multiyear deal with Nvidia earlier this week. Instead, Google has reached out to smaller hyperscalers, called neoclouds, such as Fluidstack. Google is considering a $100M investment in the startup, which provides computing power for AI companies, the report said. Google has also provided financing for Hut 8 ( HUT ), Cipher Mining ( CIFR ), and Terawulf ( WULF ), all crypto-mining companies that are transitioning to data center developers. Google has also found some traction with Anthropic ( ANTHRO ), the creator of the popular Claude AI models, for running some of its workloads on TPUs. More on Alphabet and Nvidia Nvidia: Deep Discount Before Earnings This Is A Stock Picker's Market Nvidia: The Ride Will Resume As Hyperscalers Break Their Banks Hedge fund managers give mixed signals on Nvidia Nvidia and OpenAI abandon unfinished $100B deal in favor of $30B investment: report

NVIDIA Corporation (NASDAQ:NVDA) is among the 8 Most Promising Metaverse Stocks to Buy According to Hedge Funds. NVIDIA Corporation (NASDAQ:NVDA) is one of the most promising stocks. TheFly reported on February 11 that UBS raised its price target on NVIDIA Corporation (NASDAQ:NVDA) from $235 to $245 and reiterated a Buy rating on the shares. Separately, […]

NVIDIA Corporation (NVDA) to Supply Standalone Grace CPUs in Landmark Data Center Rollout Yahoo Finance

Earnings Call Insights: Oil States International, Inc. (OIS) Q4 2025 Management View CEO Cindy Taylor reported "strong fourth quarter results with adjusted EBITDA exceeding our guidance and quarterly cash flows from operations at historically high levels." Taylor announced that $50 million of cash flow from operations was used to retire an equivalent amount of convertible senior notes, and "our cash on hand exceeded outstanding debt by $15 million at year-end." Taylor emphasized progress in "optimizing Oil States' business mix in favor of operations focused in the offshore and international markets." She noted, "77% of our revenues generated from offshore and international markets in the current quarter compared to 72% in the prior-year period." Taylor detailed that the Offshore Manufactured Products segment had "revenues and adjusted segment EBITDA increasing 13% and 12% sequentially," and that backlog reached $435 million—the highest since March 2015—with a quarterly book-to-bill ratio of 1.3x. She cited "multiple new contracts and successfully deployed advanced offshore technologies," including the "first successful deployment of our Low Impact Workover Package" and a "record deployment" of the Merlin Deepsea Mineral Riser System. CFO Lloyd Hajdik stated, "During the fourth quarter, we generated revenues of $178 million, up 8% sequentially from the third quarter and adjusted consolidated EBITDA of $23 million, representing a 9% sequential increase and at the top of the guided consolidated EBITDA range that we provided on our third quarter 2025 earnings call." Hajdik reported a "net loss of $117 million or $2.04 per share, which included long-lived asset impairments, restructuring charges and valuation allowances established on U.S. deferred tax assets." He clarified, "Our adjusted net income totaled $8 million or $0.13 per share after excluding these charges." Outlook Taylor projected "2026 full year revenues to range between $680 million and $700 million and ful...

Earnings Call Insights: Employers Holdings, Inc. (EIG) Q4 2025 Management View CEO Katherine Antonello began by addressing the elevated frequency of California cumulative trauma (CT) claims, noting "To be clear, this remains a California-specific issue. Claim frequency in our other states and within non-CT claims in California continues to trend favorably." She emphasized that Employers implemented rate increases and tightened underwriting restrictions in California and other regions, while adding, "these actions... are also likely to reduce written premium in 2026." Antonello highlighted that the Small Commercial segment maintained strong retention rates throughout 2025, attributing this to investments in automation and ease of use. She confirmed that the fourth quarter full actuarial assessment required no additional reserve strengthening, and an independent actuarial firm validated that carried reserves were within reasonable ranges. A new excess workers’ compensation product was introduced, described as "a strategic expansion of our capabilities," with Antonello reporting "the early market response has been strong, and we expect this product will deepen our distribution partner relationships while expanding our addressable market." $215 million was returned to shareholders via share repurchases and dividends in 2025. Antonello stated, "Along with our operational performance, these actions increased our book value per share, including the deferred gain by 11% to $51.31." CFO Michael Pedraja reported, "Gross premiums written were $156.8 million compared to $176.3 million for the prior year quarter, a decrease of 11% due primarily to a decrease in new business writings and lower final audit premiums, partially offset by higher renewal business premium." Pedraja added, "Our losses in LAE were $134.4 million versus $113.2 million a year ago, an increase of 18.7% due primarily to an increase in the accident year 2025 selected loss and LAE ratio and the absence of favo...

Earnings Call Insights: Comfort Systems USA, Inc. (FIX) Q4 2025 Management View Brian Lane, CEO, stated that "we reported record earnings and backlog and exceptional cash flow, thanks to best-in-class execution by our teams across the United States." Lane highlighted same-store revenue growth of 35% for the fourth quarter and a quarterly gross margin exceeding 25% for the first time in company history. He reported $9.37 per share for the quarter and $28.88 per share for the year, noting that backlog increased to a new all-time high of $12 billion with strong bookings, particularly in the technology sector. Lane shared expansion plans: "Our modular capacity is currently around 3 million square feet, and we expect to increase this to approximately 4 million square feet by the end of 2026, with planned additions in Texas and North Carolina." He also announced the acquisition of two electrical companies during the quarter and an increase in the quarterly dividend by $0.10 to $0.70 per share. CFO William George emphasized, "these results are unprecedented." George noted revenue for the fourth quarter increased by 42% year-over-year to $2.6 billion, with full-year revenue exceeding $9 billion, up 30% from 2024. He stated, "Gross profit was $675 million for the fourth quarter of 2025, a $241 million increase compared to a year ago," and pointed to margin gains in both the Mechanical and Electrical segments. George also highlighted a record $1 billion in free cash flow for the full year and substantial investments in share repurchases. President and COO Trent McKenna discussed backlog trends: "Backlog at the end of the fourth quarter was $11.9 billion, a same-store increase in both sequential and year-over-year backlog." He noted the industrial sector, especially technology/data center work, accounted for 67% of 2025's volume, with technology comprising 45% of revenue, up from 33% the prior year. Outlook McKenna expressed confidence, stating, "With unprecedented backlog and...

Earnings Call Insights: Ryerson Holding Corporation (RYI) Q4 2025 Management View CEO Edward Lehner opened the call by welcoming new leadership, including Rick Marabito as President and COO, Rich Manson as Senior Vice President of Finance, and Andrew Greiff as President of Olympic Steel and Executive VP, following the merger with Olympic Steel. Lehner stated, "We have established an experienced integration team focused on realizing the expected $120 million in annual run rate synergies...combining best practices, optimizing asset utilization and capturing combined targeted cost and revenue merger benefits." He expressed high confidence in delivering these synergies within two years. Lehner highlighted that the company is seeing "encouraging strength in customer quote and order activity relative to the past several years," and expects gross margin expansion and improved operating income both sequentially and year-over-year as pricing flows through the value chain. Regarding strategic priorities, Lehner said, "Our clear priorities are to continue integrating the combined organization...to begin realizing merger synergies...and to reduce leverage to within our targeted range with updated shareholder capital allocation plans coinciding with synergy attainment." CFO Jim Claussen commented, "Ryerson's North American shipments decreased by 6.8% sequentially and less than 0.5 percentage point for the full year, indicating market share gains for the full year of '25 despite retracement during the quarter." He reported a net loss of $38 million or $1.18 per share and adjusted EBITDA, excluding LIFO, of $20 million, below guidance expectations. Corporate Controller Molly Kannan stated, "For the fourth quarter of 2025, Ryerson reported net sales of $1.1 billion, a decrease of approximately 5% compared to the previous quarter...Compared to the fourth quarter of 2024, net sales increased by 9.7% with average selling prices 6.3% higher as well as increased tons shipped of 3.1%." O...

Microsoft Corporation (NASDAQ:MSFT) is among the 8 Most Promising Metaverse Stocks to Buy According to Hedge Funds. Microsoft Corporation (NASDAQ:MSFT) is one of the most promising stocks. TheFly reported on February 4 that Stifel downgraded MSFT from Buy to Hold and lowered its price target to $392 from $540. The analyst cited ongoing Azure supply […]

Stifel Flags Microsoft Corporation (MSFT) Azure Supply Constraints as Near-Term Growth Headwind Yahoo Finance

格隆汇2月21日｜洲际交易所：截至2月17日当周，ICE布伦特原油投机者将净多头头寸削减17,876份合约，至263,186份。

格隆汇2月21日｜洲际交易所：截至2月17日当周，ICE柴油投机者将净多头头寸削减3460份合约，至72385份。

tocks whipsawed while bonds fell alongside the dollar after the Supreme Court’s rejection of Donald Trump’s tariffs. Crypto, gold and oil mostly hovered as traders sought to assess the president’s plans for a program that sent markets careening when first announced last year. Bloomberg's Tom Keene joins to discuss on Balance of Power. (Source: Bloomberg)

The proposed ETFs are all tied to prediction markets related to U.S. elections.

Drugmakers Novo Nordisk and Eli Lilly are battling it out in the GLP-1 weight loss market. The pill version of Novo Nordisk's Ozempic has reignited competition between theses two fierce rivals. Meanwhile, another major presence in the medical world -- device maker Intuitive Surgical (NASDAQ: ISRG) -- continues to chug along. And it looks set to do so regardless of which drug company wins the GLP-1 race. Here's why you might want to add Intuitive Surgical shares to your investment portfolio. Continue reading

Vladislav Stepanov/iStock via Getty Images Overview My last evaluation of Nuvation Bio ( NUVB ) was in August 2025. While I acknowledged IBTROZI’s appeal in ROS1+ NSCLC, relative to other TKIs like AUGTYRO and ROZLYTREK, I also noted that it’s a small market and competition—in the form of Nuvalent’s ( NUVL ) zidesamtinib—was likely forthcoming. I also briefly covered Nuvation’s pipeline, with a focus on assets like safusidenib in diffuse IDH1-mutant glioma. Given IBTROZI’s apparently limited opportunity in ROS1+ NSCLC, I thought Nuvation looked overpriced at ~$450 million EV. Its stock has since skyrocketed 84%, placing my analysis at odds with the market. Data by YCharts So, I thought I’d give it another go below. IBTROZI & Preliminary Q4 Earnings Looking back at my August analysis, I believe I missed the mark. Although my analysis balanced IBTROZI’s best-in-class status with a small ROS1+ NSCLC TAM, in hindsight, it didn’t make much sense for me to assume a bearish stance at a $400 million EV. The past is the past, and I am now tasked with evaluating Nuvation in light of recent developments and its newfound ~$1.5 billion EV. First and foremost, let’s formally model IBTROZI in ROS1+ NSCLC. IBTROZI is a fully approved drug, so the Probability of Success, or POS, is set to 100%. It launched last year. Nuvation’s own target market is 3,000 (midpoint; Slide 19 ) patients. Pricing of $225,000/year is net (what the company recognizes after rebates and discounts), not list (or gross) price. Net pricing is an estimate. I modeled for a peak share of 60%, which is high, especially given there are a few other TKIs approved in ROS1+ NSCLC. 60% acknowledge that IBTROZI is the preferred agent. U.S. Market Only (Author's Compilation) The risk-adjusted net present value comes out to roughly $1.065 billion. Last month, Nuvation announced preliminary Q4/FY25 earnings (the actual earnings announcement date is 3/2/2026). Preliminary IBTROZI net product revenue came in at $15.7 million...

【有線新聞】創新科技發展迅速，當中亦愈來愈多應用在醫療範疇，有醫院為住院病人引入穿戴式智慧裝置，再配合人工智能技術，可以無障礙實時監察病人心跳頻率等維生指數。 護士：「我們待會幫你貼一個小型的裝置，就可以在住院期間監察你的心跳和心率情況。如果有些很突發的情況、很嚴重的情況就會通知我們。」天水圍醫院內科（呼吸科）副顧問護師唐偉鴻：「安心貼，我們相對會給一些中風險，可能病人可以自由行走，但又未至於很嚴重的情況。很高風險會去轉差的，但始終都有機會轉差的病人，我們就會用這個持續監測心臟、心律的情況。」 以往所用的傳統心臟監測儀器體積較大型，而且有不少電線接駁，使用上的限制較多。唐偉鴻：「因為始終大型的一些心臟監察儀器數量有限，加上可能會大型也有很多線。當病人沒有這些儀器監察的時候，萬一他突然轉差例如心臟停頓，醫護人員真的未必可以即時發現。」 這個穿戴式裝置體積較小，充電一次可以使用2至3天。由於無需要接駁任何電線，使用者可以在醫院特定範圍內走動。裝置一般會貼在使用者的胸口位置，主要適合一些患有心血管疾病或呼吸系統有風險的病人使用，「這個畫面就是如果在病房中正在監察，用安心貼監察病人，如果某個病人突然心跳很快，好像這裡的顯示，他的心跳去到190每分鐘，那麼他的心率就會即時在這裡提示。」 裝置除了有監察心跳、心律等功能外，它還可以偵測使用者有否跌倒或離開病房，確保病人的健康及安全。新界西醫院聯網資訊科技統籌雷俊達醫生：「因為有時候有些人有認知障礙，老人家可能有風險，有機會自己在病房走出去。在這些情況當離開病房門口，其實系統就會觸發警報，然後就會通知我們的前線護士同事立即找回他，那麼病人就更安全。」 目前這個裝置在醫管局新界西聯網旗下的天水圍醫院已經試運大約一年，共有超過1,000名病人使用過。在試行期間有超過100位病人在穿戴期間病況出現異常，監察系統成功通知醫護人員作出相應跟進及治療。

wichianduangsri/E+ via Getty Images Finding Yield in Asia Pacific Markets APAC debt and equity investments have had stellar performance in recent years, most notably in 2025 when international markets soared due to diversification measures from investors and the stellar performance of foreign currencies. Data by YCharts The abrdn Asia-Pacific Income Fund ( FAX ) is an interesting high-yield vehicle to consider, which has had stellar performance in recent years. FAX returned over 17% in the past twelve months, well ahead of many other fixed income investments. The main issue to consider moving forward is its high fee structure and weaker relative performance during previous cycles. The Asia Pacific region has strong growth potential in the coming years, and a combination of fixed income and equity investing in this environment is ideal. This article will discuss FAX's appeal relative to other Asia Pacific vehicles and also cover other international fixed income investments. abrdn Asia-Pacific Income Fund The fund is an excellent vehicle for investors who are searching for higher yields in international markets, including Asia Pacific. FAX's use of leverage has allowed recent yields to surpass those in many emerging market debt funds. While returns have been very flat over the past decade, they have picked up in the past couple of years. FAX has returned by around 12% per annum in the past three years, compared to its 6.6% average since its inception. Aberdeen FAX has returned by 37.6% during the past three years, slightly underperforming the State Street S&P Emerging Asia Pacific ETF during most of this three-year period. This proximity of FAX to some of its peer equity market bull runs, relative to other debt and equity investments in the United States, makes it worthwhile to check out this higher-yield play. Data by YCharts There are several factors investors should note about FAX. Although it primarily focuses on the Asia Pacific region, there are some out of plac...

格隆汇2月21日｜美联储洛根：各国央行之间的良好关系有利于市场和美国经济。

Richard Drury/DigitalVision via Getty Images The VanEck AA-BB CLO ETF ( CLOB ) is exactly what it says on the tin: an AA-BB CLO ETF. CLOB's portfolio is a bit more diversified than those of its CLO peers, with a solid 6.5% dividend yield and an above-average performance track record. Risks are below average, if a tad higher than expected considering the fund's strong credit quality. Overall, CLOB is a strong investment opportunity and a buy. CLOB - Overview and Analysis Strategy and Portfolio CLOB is an actively managed diversified CLO ETF. In short, CLOs are securitized portfolios of variable-rate corporate loans with varying degrees of credit risk. We wrote a longer explanation the last time we covered it here . CLOB is relatively unique in the CLO space due to investing in CLOs of several credit ratings, from AA to BB. It does focus on the higher-quality CLOs, with over 80% of its portfolio being investment grade and over 40% being AA. CLOB CLOB is actively managed, as are, I think, all CLO ETFs. Active management means potentially higher income and returns, contingent on management making profitable, effective investment decisions. Risks are higher too, insofar as management can make unprofitable decisions too. I think the risks here are more minor due to the fund's diversified, quality holdings: there is simply less room for error for higher-quality investments. Risk and Volatility CLOB focuses on high-quality CLOs, so credit risk is quite low. One would expect high-quality CLOs to experience relatively few losses during downturns and recessions, but from prior coverage, losses tend to be moderate, sometimes high. In my opinion, this is due to illiquidity and due to perceptions of risk: investors think of CLOs as risky, so they sell these when times are tough. With its inception in early 2025, CLOB has yet to experience a meaningful downturn or recession, so we can't really analyze its performance during one. The closest event to a recession was the equity bear...

格隆汇2月21日｜美联储洛根：希望为美联储回购操作提供中央清算。

格隆汇2月21日｜美联储洛根：银行确保已准备好获取流动性至关重要。

CNN记者在X上发帖称，美军“杰拉尔德·R·福特”号航母打击群目前已进入地中海，正前往中东与该国其它军事力量会合。 责任编辑：李桐

Manchester United co-owner reminded of his responsibilities in media interviews as Carrick backs club’s culture of respect Continue reading...